>
pdufa.bio

Temozolomide

Updated ยทnext FDA decision on the calendar

Temozolomide is a NovoCure Limited program. Its next catalyst is a Readout in Aug 2027. Every date links its source.

NVCR catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: NovoCure Limited (NVCR). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Aug 2027NVCR

Questions

When is Temozolomide's next FDA decision or readout?

The next tracked catalyst for Temozolomide is a Readout in Aug 2027.

What happened at Temozolomide's most recent FDA decision?

No FDA decision for Temozolomide is in our archive yet.

Who makes Temozolomide?

NovoCure Limited (NVCR).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.